Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 485

1.

The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectives.

Ceriello A, deValk HW, Guerci B, Haak T, Owens D, Canobbio M, Fritzen K, Stautner C, Schnell O.

Diabetes Res Clin Pract. 2020 Feb 5;161:108053. doi: 10.1016/j.diabres.2020.108053. [Epub ahead of print] Review.

PMID:
32035117
2.

Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes.

Harris S, Abrahamson MJ, Ceriello A, Charpentier G, Evans M, Lehmann R, Liebl A, Linjawi S, Holt RIG, Hosszúfalusi N, Rutten G, Vilsbøll T.

Drugs. 2020 Feb;80(2):147-165. doi: 10.1007/s40265-019-01245-3. Review.

3.

Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity.

Garavelli S, Bruzzaniti S, Tagliabue E, Prattichizzo F, Di Silvestre D, Perna F, La Sala L, Ceriello A, Mozzillo E, Fattorusso V, Mauri P, Puca AA, Franzese A, Matarese G, Galgani M, de Candia P.

Int J Mol Sci. 2020 Jan 11;21(2). pii: E477. doi: 10.3390/ijms21020477.

4.

Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.

Nicolucci A, Ceriello A, Di Bartolo P, Corcos A, Orsini Federici M.

Diabetes Ther. 2019 Dec 23. doi: 10.1007/s13300-019-00732-w. [Epub ahead of print] Review.

PMID:
31873857
5.

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514-519.

Ceriello A, Rossi MC, De Cosmo S, Lucisano G, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, Russo G, Nicolucci A; AMD-Annals Study Group.

Diabetes Care. 2020 Feb;43(2):497. doi: 10.2337/dc20-er02. Epub 2019 Dec 11. No abstract available.

6.

The Plant Health Monitoring System of the EDEN ISS Space Greenhouse in Antarctica During the 2018 Experiment Phase.

Zeidler C, Zabel P, Vrakking V, Dorn M, Bamsey M, Schubert D, Ceriello A, Fortezza R, De Simone D, Stanghellini C, Kempkes F, Meinen E, Mencarelli A, Swinkels GJ, Paul AL, Ferl RJ.

Front Plant Sci. 2019 Nov 22;10:1457. doi: 10.3389/fpls.2019.01457. eCollection 2019.

7.

Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases.

Prattichizzo F, La Sala L, Rydén L, Marx N, Ferrini M, Valensi P, Ceriello A.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):73-80. doi: 10.1177/2047487319880040.

PMID:
31766918
8.

Targets for blood glucose: What have the trials told us.

Valensi P, Prévost G, Schnell O, Standl E, Ceriello A.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):64-72. doi: 10.1177/2047487319885456.

PMID:
31766916
9.

The link between diabetes and atherosclerosis.

La Sala L, Prattichizzo F, Ceriello A.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):15-24. doi: 10.1177/2047487319878373. Epub 2019 Nov 13.

PMID:
31722564
10.

Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.

Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):25-32. doi: 10.1177/2047487319878371. Epub 2019 Nov 13.

PMID:
31722562
11.

Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.

Nusca A, Tuccinardi D, Proscia C, Melfi R, Manfrini S, Nicolucci A, Ceriello A, Pozzilli P, Ussia GP, Grigioni F, Di Sciascio G.

Cardiovasc Diabetol. 2019 Nov 9;18(1):147. doi: 10.1186/s12933-019-0952-8.

12.

Two drugs are better than one to start T2DM therapy.

Prattichizzo F, La Sala L, Ceriello A.

Nat Rev Endocrinol. 2020 Jan;16(1):15-16. doi: 10.1038/s41574-019-0294-3. No abstract available.

PMID:
31705131
13.

Intensive Glucose Control and Type 2 Diabetes - 15 Years On.

Ceriello A, Nicolucci A.

N Engl J Med. 2019 Sep 26;381(13):1292-1293. doi: 10.1056/NEJMc1909041. No abstract available.

PMID:
31553849
14.

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group .

Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486. No abstract available.

PMID:
31497854
15.

Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?

Giugliano D, Ceriello A, De Nicola L, Perrone-Filardi P, Cosentino F, Esposito K.

Diabetes Obes Metab. 2020 Feb;22(2):149-157. doi: 10.1111/dom.13881. Epub 2019 Oct 17. Review.

PMID:
31495989
16.

Extracellular vesicles circulating in young organisms promote healthy longevity.

Prattichizzo F, Giuliani A, Sabbatinelli J, Mensà E, De Nigris V, La Sala L, de Candia P, Olivieri F, Ceriello A.

J Extracell Vesicles. 2019 Aug 15;8(1):1656044. doi: 10.1080/20013078.2019.1656044. eCollection 2019.

17.

Corrigendum to "Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?"

Giuliani A, Prattichizzo F, Micolucci L, Ceriello A, Procopio AD, Rippo MR.

Mediators Inflamm. 2019 Aug 14;2019:8716351. doi: 10.1155/2019/8716351. eCollection 2019.

18.

Type 2 Diabetes: How Much of an Autoimmune Disease?

de Candia P, Prattichizzo F, Garavelli S, De Rosa V, Galgani M, Di Rella F, Spagnuolo MI, Colamatteo A, Fusco C, Micillo T, Bruzzaniti S, Ceriello A, Puca AA, Matarese G.

Front Endocrinol (Lausanne). 2019 Jul 4;10:451. doi: 10.3389/fendo.2019.00451. eCollection 2019.

19.

From pump to sink: The hydraulic connection of type 2 diabetes.

Giugliano D, Esposito K, Ceriello A.

Diabetes Res Clin Pract. 2020 Jan;159:107772. doi: 10.1016/j.diabres.2019.06.013. Epub 2019 Jun 28. No abstract available.

PMID:
31260714
20.

Author Correction: A rare genetic variant of BPIFB4 predisposes to high blood pressure via impairment of nitric oxide signaling.

Vecchione C, Villa F, Carrizzo A, Spinelli CC, Damato A, Ambrosio M, Ferrario A, Madonna M, Uccellatore A, Lupini S, Maciag A, Ryskalin L, Milanesi L, Frati G, Sciarretta S, Bellazzi R, Genovese S, Ceriello A, Auricchio A, Malovini A, Puca AA.

Sci Rep. 2019 Jun 28;9(1):9574. doi: 10.1038/s41598-019-45691-1.

21.

Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations.

Livesey G, Taylor R, Livesey HF, Buyken AE, Jenkins DJA, Augustin LSA, Sievenpiper JL, Barclay AW, Liu S, Wolever TMS, Willett WC, Brighenti F, Salas-Salvadó J, Björck I, Rizkalla SW, Riccardi G, Vecchia C, Ceriello A, Trichopoulou A, Poli A, Astrup A, Kendall CWC, Ha MA, Baer-Sinnott S, Brand-Miller JC.

Nutrients. 2019 Jun 25;11(6). pii: E1436. doi: 10.3390/nu11061436.

22.

Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: A Systematic Review and Updated Meta-Analyses of Prospective Cohort Studies.

Livesey G, Taylor R, Livesey HF, Buyken AE, Jenkins DJA, Augustin LSA, Sievenpiper JL, Barclay AW, Liu S, Wolever TMS, Willett WC, Brighenti F, Salas-Salvadó J, Björck I, Rizkalla SW, Riccardi G, La Vecchia C, Ceriello A, Trichopoulou A, Poli A, Astrup A, Kendall CWC, Ha MA, Baer-Sinnott S, Brand-Miller JC.

Nutrients. 2019 Jun 5;11(6). pii: E1280. doi: 10.3390/nu11061280.

23.

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice.

Evans M, Ceriello A, Danne T, De Block C, DeVries JH, Lind M, Mathieu C, Nørgaard K, Renard E, Wilmot EG.

Diabetes Obes Metab. 2019 Sep;21(9):2039-2047. doi: 10.1111/dom.13798. Epub 2019 Jun 19. Review.

24.

The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice.

Ceriello A, De Nigris V, Iijima H, Matsui T, Gouda M.

Drugs. 2019 May;79(7):733-750. doi: 10.1007/s40265-019-01086-0. Review.

25.

Triple-layer Mesh Plasty for Re-recurrent Ventral Hernia in a Liver Transplant Patient: A Case Report.

Pisaniello D, Monti G, Ceriello A, Santaniello W, Calise F, Cuomo O.

Transplant Proc. 2019 Mar;51(2):589-592. doi: 10.1016/j.transproceed.2018.12.020. Epub 2019 Jan 3.

PMID:
30879596
26.

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.

Schnell O, Standl E, Catrinoiu D, Itzhak B, Lalic N, Rahelic D, Skrha J, Valensi P, Ceriello A.

Cardiovasc Diabetol. 2019 Mar 11;18(1):30. doi: 10.1186/s12933-019-0822-4.

27.

Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes.

Viazzi F, Bonino B, Mirijello A, Fioretto P, Giorda C, Ceriello A, Guida P, Russo GT, De Cosmo S, Pontremoli R; AMD-Annals Study Group.

J Hypertens. 2019 Apr;37(4):805-813. doi: 10.1097/HJH.0000000000001950.

PMID:
30817462
28.

Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D.

La Sala L, Mrakic-Sposta S, Tagliabue E, Prattichizzo F, Micheloni S, Sangalli E, Specchia C, Uccellatore AC, Lupini S, Spinetti G, de Candia P, Ceriello A.

Cardiovasc Diabetol. 2019 Feb 25;18(1):18. doi: 10.1186/s12933-019-0824-2.

29.

Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study.

Ceriello A, Rossi MC, De Cosmo S, Lucisano G, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, Russo G, Nicolucci A; AMD-Annals Study Group.

Diabetes Care. 2019 Apr;42(4):514-519. doi: 10.2337/dc18-1471. Epub 2019 Feb 14. Erratum in: Diabetes Care. 2020 Feb;43(2):497.

PMID:
30765432
30.

Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes.

Viazzi F, Bonino B, Mirijello A, Fioretto P, Giorda C, Ceriello A, Guida P, Russo GT, De Cosmo S, Pontremoli R; AMD-Annals Study Group.

J Hypertens. 2019 Jan 7. doi: 10.1097/HJH.0000000000001950. [Epub ahead of print]

PMID:
30624364
31.

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes.

Mirijello A, Viazzi F, Fioretto P, Giorda C, Ceriello A, Russo GT, Guida P, Pontremoli R, De Cosmo S; AMD ANNALS Study Group.

BMC Nephrol. 2018 Dec 4;19(1):347. doi: 10.1186/s12882-018-1136-6.

32.

Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals.

Viazzi F, Russo GT, Ceriello A, Fioretto P, Giorda C, De Cosmo S, Pontremoli R.

J Nephrol. 2019 Aug;32(4):517-525. doi: 10.1007/s40620-018-00561-3. Epub 2018 Nov 27. Review.

PMID:
30478509
33.

Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.

Cosentino F, Ceriello A, Baeres FMM, Fioretto P, Garber A, Stough WG, George JT, Grant PJ, Khunti K, Langkilde AM, Plutzky J, Rydén L, Scheen A, Standl E, Tuomilehto J, Zannad F.

Eur Heart J. 2019 Sep 7;40(34):2907-2919. doi: 10.1093/eurheartj/ehy677. No abstract available.

PMID:
30445605
34.

Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.

Prattichizzo F, Giuliani A, Mensà E, Sabbatinelli J, De Nigris V, Rippo MR, La Sala L, Procopio AD, Olivieri F, Ceriello A.

Ageing Res Rev. 2018 Dec;48:87-98. doi: 10.1016/j.arr.2018.10.003. Epub 2018 Oct 15. Review.

PMID:
30336272
35.

Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions.

Gentile S, Strollo F, Viazzi F, Russo G, Piscitelli P, Ceriello A, Giorda C, Guida P, Fioretto P, Pontremoli R, De Cosmo S, The Amd-Annals Study Group.

J Diabetes Res. 2018 Sep 19;2018:7153087. doi: 10.1155/2018/7153087. eCollection 2018.

36.

Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L).

Bergman M, Manco M, Sesti G, Dankner R, Pareek M, Jagannathan R, Chetrit A, Abdul-Ghani M, Buysschaert M, Olsen MH, Nilsson PM, Medina JL, Roth J, Groop L, Del Prato S, Raz I, Ceriello A.

Diabetes Res Clin Pract. 2018 Dec;146:18-33. doi: 10.1016/j.diabres.2018.09.017. Epub 2018 Sep 28. Review.

PMID:
30273707
37.

Glycaemic variability in diabetes: clinical and therapeutic implications.

Ceriello A, Monnier L, Owens D.

Lancet Diabetes Endocrinol. 2019 Mar;7(3):221-230. doi: 10.1016/S2213-8587(18)30136-0. Epub 2018 Aug 13. Review.

PMID:
30115599
38.

Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative.

Lamacchia O, Viazzi F, Fioretto P, Mirijello A, Giorda C, Ceriello A, Russo G, Guida P, Pontremoli R, De Cosmo S.

Diabetol Metab Syndr. 2018 Jul 31;10:60. doi: 10.1186/s13098-018-0361-2. eCollection 2018.

39.

Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low-grade inflammation the neglected component?

Prattichizzo F, De Nigris V, Micheloni S, La Sala L, Ceriello A.

Diabetes Obes Metab. 2018 Nov;20(11):2515-2522. doi: 10.1111/dom.13488. Epub 2018 Sep 6. Review.

PMID:
30073768
40.

Real-world use of self-monitoring of blood glucose in people with type 2 diabetes: an urgent need for improvement.

Rossi MC, Lucisano G, Ceriello A, Mazzucchelli C, Musacchio N, Ozzello A, Nicolucci A, Di Bartolo P; AMD Annals-SMBG Study Group.

Acta Diabetol. 2018 Oct;55(10):1059-1066. doi: 10.1007/s00592-018-1186-z. Epub 2018 Jul 30.

PMID:
30062588
41.

Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability.

La Sala L, Mrakic-Sposta S, Micheloni S, Prattichizzo F, Ceriello A.

Cardiovasc Diabetol. 2018 Jul 23;17(1):105. doi: 10.1186/s12933-018-0748-2.

42.

The Berlin Declaration: A call to improve early actions related to type 2 diabetes. Why is primary care important?

Khunti K, Gavin JR 3rd, Boulton AJM, Blickstead R, McGill M, Ceriello A, Raz I, Sadikot S, Wood DA, Cos X, Kalra S, Das AK, Espinosa López C; Berlin Declaration Steering Group.

Prim Care Diabetes. 2018 Oct;12(5):383-392. doi: 10.1016/j.pcd.2018.04.003. Epub 2018 May 8. Review.

PMID:
29752222
43.

Novel insights into the regulation of miRNA transcriptional control: implications for T2D and related complications.

La Sala L, Micheloni S, De Nigris V, Prattichizzo F, Ceriello A.

Acta Diabetol. 2018 Oct;55(10):989-998. doi: 10.1007/s00592-018-1149-4. Epub 2018 May 7. Review.

PMID:
29732466
44.

Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes.

Viazzi F, Greco E, Ceriello A, Fioretto P, Giorda C, Guida P, Russo G, De Cosmo S, Pontremoli R; AMD-Annals Study Group.

Kidney Blood Press Res. 2018;43(2):422-438. doi: 10.1159/000488255. Epub 2018 Mar 16.

45.

Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study.

Viazzi F, Ceriello A, Fioretto P, Giorda C, Guida P, Russo G, Greco E, De Cosmo S, Pontremoli R; AMD-Annals Study Group.

J Hypertens. 2018 Aug;36(8):1719-1728. doi: 10.1097/HJH.0000000000001749.

PMID:
29677050
46.

Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative.

Piscitelli P, Viazzi F, Fioretto P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Pontremoli R, De Cosmo S.

Sci Rep. 2018 Apr 12;8(1):5999. doi: 10.1038/s41598-018-23163-2.

47.

The Berlin Declaration: A call to action to improve early actions related to type 2 diabetes. How can specialist care help?

Ceriello A, Gavin JR 3rd, Boulton AJM, Blickstead R, McGill M, Raz I, Sadikot S, Wood DA, Cos X, Khunti K, Kalra S, Das AK, López CE; Berlin Declaration Steering Group.

Diabetes Res Clin Pract. 2018 May;139:392-399. doi: 10.1016/j.diabres.2018.03.037. Epub 2018 Mar 27.

PMID:
29596943
48.

Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions.

De Nigris V, Prattichizzo F, Mancuso E, Spiga R, Pujadas G, Ceriello A.

Oncotarget. 2017 Dec 1;9(10):8898-8910. doi: 10.18632/oncotarget.22849. eCollection 2018 Feb 6.

49.

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.

Schnell O, Standl E, Catrinoiu D, Genovese S, Lalic N, Lalic K, Skrha J, Valensi P, Ceriello A.

Cardiovasc Diabetol. 2018 Feb 19;17(1):30. doi: 10.1186/s12933-018-0667-2.

50.

Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?

Giuliani A, Prattichizzo F, Micolucci L, Ceriello A, Procopio AD, Rippo MR.

Mediators Inflamm. 2017;2017:2309034. doi: 10.1155/2017/2309034. Epub 2017 Dec 27. Review. Erratum in: Mediators Inflamm. 2019 Aug 14;2019:8716351.

Supplemental Content

Loading ...
Support Center